Data from multiple sources - Curated by Toby Galbraith - Last updated 06 June 2017

Latest news articles

Added 1 month ago Drug news

Phase III COMPASS study shows Xarelto (rivaroxaban)+ aspirin significantly reduced major CV events.- Janssen Research Development + Bayer HealthCare.

Results from the pivotal Phase III COMPASS study found that the Xarelto (rivaroxaban) vascular dose (2.5 mg twice daily) plus...

Added 1 month ago Drug news

Sub-analysis of data from the Phase III PEGASUS-TIMI 54 trial of Brilinta demonstrated a 29% risk reduction in CV death.- AstraZeneca.

AstraZeneca announced results from a new sub-analysis of data from the Phase III PEGASUS-TIMI 54 trial demonstrating a 29% risk...

Added 3 months ago Drug news

Study of PCI patients with Impella 2.5 heart pump published in Journal of Interventional Cardiology- Abiomed

Abiomed announced the publication of a peer-reviewed retrospective study on hemodynamic support with the Impella 2.5 heart pump. The study...

Search all news articles for Acute myocardial infarction
 

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Allergic Rhinitis

Allergic rhinitis causes great strain on the workforce. Help to reduce sick days and improve productivity with appropriate treatment options.

Visit Allergic Rhinitis

Breakthrough Cancer Pain Learning Zone

Invitation to watch the online broadcast of the BeCOn OWN event 'Shifting paradigms in BTcP management' on June 16 2017.

Visit Breakthrough Cancer Pain Learning Zone

Guidelines

Acute coronary syndrome

This guideline provides recommendations for the management of patients with ACS within the first 12 hours and up to hospital discharge.

Added 7 days ago

European Guidelines for the management of acute coronary syndromes in patients presenting wihout persistent ST-segment elevation

The present document deals with the management of patients with suspected NSTE-ACS, replacing the document first published in 2000 and...

Added 2 years ago

ESC/EACTS Guidelines on Myocardial Revascularisation

In 2014, coronary artery bypass grafting (CABG) celebrates the 50th anniversary of the first procedures performed in 1964. Thirteen years...

Added 3 years ago

Search all guidelines for Acute myocardial infarction
 

Journal articles

Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease.

Background: We evaluated whether rivaroxaban alone or in combination with aspirin would be more effective than aspirin alone for secondary cardiovascular prevention.

Added 21 days ago

Adherence to Rivaroxaban Compared with Other Oral Anticoagulant Agents Among Patients with Nonvalvular Atrial Fibrillation.

Background: Adherence to oral anticoagulant (OAC) agents is important for patients with nonvalvular atrial fibrillation (NVAF) to prevent potentially severe adverse events.

Added 21 days ago

Comparative effectiveness of rivaroxaban versus warfarin or dabigatran for the treatment of patients with non-valvular atrial fibrillation.

Background: Rivaroxaban is an oral anticoagulant approved in the US for prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation (NVAF).

Added 21 days ago

Search all journal articles for Acute myocardial infarction
 

Clinical trials

Rivaroxaban for the Prevention of Major Cardiovascular Events in Coronary or Peripheral Artery Disease (COMPASS)

The primary purpose of this study is to evaluate whether treatment with rivaroxaban and aspirin or rivaroxaban alone is better than aspirin alone in prevention of heart attacks, stroke or cardiovascular death...

Added 5 years ago

An Efficacy and Safety Study for Rivaroxaban in Patients With Acute Coronary Syndrome

The purpose of this study is to determine whether rivaroxaban in addition to standard care reduces the risk of the composite of cardiovascular death, myocardial infarction, or stroke in patients...

Added 21 days ago

Search all clinical trials for Acute myocardial infarction
 
Peter English

Doctor in public health and health protection. Particular interests in vaccination (editor of journal Vaccines in Practice) and health informatics/intelligence. I blog and post in a personal capacity: nothing I write here should be assumed to represent the views of anybody other than ... Read more

The advance decision not to attempt cardiopulmonary resuscitation

Decisions to start cardiopulmonary resuscitation (CPR), or to decide in advance to issue a "do not attempt (cardiopulmonary) resuscitation" (DNAR) notice have always been a hot topic in clinical medicine. It may have become even more so since a recent (June 2014) court decision. This post discusses some of the issues and legalities around DNAR decisions.

CME

Cardiac rehabilitation

Accrediting body
Union of European Medical Specialists (via European Accreditation Council for CME)
Credits available
1
Registration required
1
Subscription fee
90
Search all CME for Acute myocardial infarction